Substrate ·evidence-based
interventions / Ashwagandha / blood sugar

Does Ashwagandha help blood sugar? (Grade C evidence)

Explore current source-reported research for this exact question. These records are separate from the synthesis below; they do not update its grade or establish a recommendation.

Ashwagandha may modestly help blood sugar in specific populations (Grade C, low certainty), especially in adults with diabetes or elevated blood glucose. Dose range: not standardized across trials.

Exact question reviewed

Population
adults with diabetes or elevated blood glucose
Intervention
Ashwagandha · not standardized across trials
Comparator
not reported
Outcome
blood sugar
Time horizon
not reported

Bottom line. Ashwagandha may modestly help blood sugar in specific populations (Grade C, low certainty), especially in adults with diabetes or elevated blood glucose. Dose range: not standardized across trials. [1 SR/meta]

Direction
benefit
Magnitude
Systematic review and meta-analysis of Withania somnifera (ashwagandha) in diabetes: pooled data suggest a possible glucose-lowering effect, but the authors conclude the anti-diabetic profile is not yet established and call for larger, longer randomized trials measuring blood glucose, HbA1c and insulin. Signal, not confirmation.
Grade
C
Certainty
low
Clinical meaning
small but potentially useful
Who it applies to
adults with diabetes or elevated blood glucose
Dose / form studied
not standardized across trials
Safety
moderate_with_ssri
The one limitation
Claim-specific limitation details are not available in this public record.

Reviewed not reported · Evidence last changed · Open evidence record (version 0)

⚠ Safety in context

Grade
C
what does the grade mean?
Certainty
low
what does certainty mean?

Grade C / low: hints of benefit in small trials; a well-run RCT could easily push this to B or to null.

Who it works for

Best-studied in adults with diabetes or elevated blood glucose. Recorded studied dose: not standardized across trials.

Evidence

StudyDesignRoleCite
Withania somnifera (Indian ginseng) in diabetes mellitus: A systematic review and meta-analysis of scientific evidence from experimental research to clinical application.peer-reviewedsupportsPMID:31975514

Why this grade

Reasoning trace

The current record stores Grade C at low certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.

Audit and version

Claim ID
ec_b6-ash-blood-sugar
Claim version
not reported
Governance
legacy, not verified
Clinician review
Not yet reviewed by a licensed clinician
Last evidence search
not reported
Last editorial review
not verified

Public receipt · Machine-readable claim · Methodology

Dose & form

Studied intake: not standardized across trials.

How it stacks up for blood sugar

Grade history

No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+). Methodology v1.

Re-review cadence: every 6 months (Grade C+) · methodology v1.

Frequently asked

How long does Ashwagandha take to work for blood sugar?

This record does not report a studied onset time for Ashwagandha and blood sugar. Do not assume a typical timeframe.

What dose was used in studies of Ashwagandha for blood sugar?

The recorded studied dose for Ashwagandha and blood sugar is not standardized across trials. This is a source detail, not a dose recommendation.

Does Ashwagandha work for blood sugar if I'm not deficient?

The recorded studied population is adults with diabetes or elevated blood glucose. This field alone does not show whether deficiency or baseline status changes the effect.

Ashwagandha or the next-best alternative for blood sugar?

See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.

Related

What this is — and is not

Evidence description
Systematic review and meta-analysis of Withania somnifera (ashwagandha) in diabetes: pooled data suggest a possible glucose-lowering effect, but the authors conclude the anti-diabetic profile is not yet established and call for larger, longer randomized trials measuring blood glucose, HbA1c and insulin. Signal, not confirmation.
Substrate's interpretation
The current reviewed record assigns Grade C at low certainty. A domain-by-domain rationale is shown only when recorded.
Discuss with a clinician
If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
Individualized medical advice
Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.

Cite this page

Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.

Plain-text citation
Substrate. Does Ashwagandha help blood sugar? (Grade C). https://evidencebased.info/interventions/ashwagandha/blood-sugar. Updated 2026-07-16.
BibTeX
@misc{substrate_shwagandhabloodsugar,
  author = {Substrate editorial},
  title  = {Does Ashwagandha help blood sugar?},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/ashwagandha/blood-sugar},
  note   = {Grade C, evidencebased.info}
}

Found something wrong on this page? Report an error →

Current source-reported research

Membership uses admitted intervention and measured-outcome associations for this exact question. Different populations, preparations, comparators and timepoints remain separate. No pooling or update to the synthesis is asserted.